Flexion Therapeutics, Inc.

Verona Pharma plc entered into agreements that give the company access to as much as $650m in new debt and other financing, bringing its new cash potential to more than $1bn after starting the year w

Atlas Venture added more fuel to its biotechnology start-up engine with a $450m fund announced on 3 March, which the venture capital firm will invest in new companies developing novel therapeutics and

Pacira BioSciences, Inc. ’s planned acquisition of Flexion Therapeutics, Inc. and its osteoarthritis of the knee injectable Zilretta will allow the company to expand its offering of non-opioid drugs

Bone Therapeutics SA may find itself with limited options for its lead product candidate, JTA-004, following the failure of its Phase III trial in knee osteoarthritis pain. Although a post-hoc analys